Related references
Note: Only part of the references are listed.Successful Brincidofovir Treatment of Metagenomics-detected Adenovirus Infection in a Severely Ill Signal Transducer and Activator of Transcription-1-deficient Patient
Diana Averbuch et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)
Antiviral activity of brincidofovir on parvovirus B19
Gloria Bua et al.
ANTIVIRAL RESEARCH (2019)
Oral Brincidofovir Decreased HHV-6 Viremia in Hematopoietic Cell Transplant Recipients: Results from the Suppress Study
Joshua A Hill et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M. Marty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Approach to infection and disease due to adenoviruses in solid organ transplantation
Diana F. Florescu et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant
Jagdish P. Meena et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2019)
Updates on antiviral drugs for cytomegalovirus prevention and treatment
Camille N. Kotton
CURRENT OPINION IN ORGAN TRANSPLANTATION (2019)
In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review
Roy F. Chemaly et al.
ANTIVIRAL RESEARCH (2019)
Brincidofovir Decreases Adenovirus Viral Burden, Which is Associated with Improved Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Thomas M. Brundage et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD
Claire J. Detweiler et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)
Brincidofovir as Salvage Therapy for Adenovirus Disease in Intestinal Transplant Recipients
Nimisha Sulejmani et al.
PHARMACOTHERAPY (2018)
Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients
Yeon Joo Lee et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
1421. IV Brincidofovir (BCV): Pharmacokinetics (PK) and Safety of Multiple Ascending Doses (MAD) in Healthy Subjects
Odin Naderer et al.
Open Forum Infectious Diseases (2018)
Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
Kaiwen Chen et al.
BLOOD ADVANCES (2018)
Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation
Michael Slade et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - Case series and 10 year experience of management in an adult transplant cohort
Isobel D. Ramsay et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects
Mary Beth Wire et al.
Open Forum Infectious Diseases (2017)
Approach to adenovirus infections in the setting of hematopoietic cell transplantation
Yeon Joo Lee et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2017)
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant
Prashant Hiwarkar et al.
BLOOD (2017)
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial
Michael S. Grimley et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience
Danielle El-Haddad et al.
ANTIVIRAL RESEARCH (2016)
Adenovirus Viremia in Adult CD34+ Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact
Yeon Joo Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
Firas El Chaer et al.
BLOOD (2016)
Cutaneous involvement of disseminated adenovirus infection in an allogeneic stem cell transplant recipient
A. Keyes et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
The use of brincidofovir for the treatment of mixed dsDNA viral infection
Jose F. Camargo et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
Emmanuel Faure et al.
MEDICINE (2016)
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation
S. Voigt et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host
K. M. Mullane et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
Brincidofovir for Polyomavirus-Associated Nephropathy After Allogeneic Hematopoietic Stem Cell Transplantation
Genovefa A. Papanicolaou et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
The Effect of Cidofovir on Adenovirus Plasma DNA Levels in Stem Cell Transplantation Recipients without T Cell Reconstitution
Gertjan Lugthart et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Adenovirus Infections in Immunocompetent and Immunocompromised Patients
Thomas Lion
CLINICAL MICROBIOLOGY REVIEWS (2014)
Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses
Diana F. Florescu et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Brincidofovir (CMX001) for the Treatment of Serious or Life-Threatening Double-Stranded DNA Virus Infections in Patients Receiving Liver Transplant as Part of Multiorgan Transplantation
D. Florescu et al.
TRANSPLANTATION (2014)
Selection and Recombinant Phenotyping of a Novel CMX001 and Cidofovir Resistance Mutation in Human Cytomegalovirus
Scott H. James et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The human polyomavirus BK (BKPyV): virological background and clinical implications
Christine Hanssen Rinaldo et al.
APMIS (2013)
HDP-CDV as an alternative for treatment of human herpesvirus-6 infections
Pascale Bonnafous et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
FATAL ADENOVIRUS ENCEPHALOMYELORADICULITIS IN AN UMBILICAL CORD STEM CELL TRANSPLANT RECIPIENT
Oluwole O. Awosika et al.
NEUROLOGY (2013)
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
Francisco M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses
Wendy Painter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients
Diana F. Florescu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction
Jose G. Montoya et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001
Kris Paolino et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient
Yuji Isegawa et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model
Karoly Toth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients
Usman Yusuf et al.
TRANSPLANTATION (2006)
Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro
SL Williams-Aziz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients
B Heemskerk et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease
T Lion et al.
BLOOD (2003)
Smallpox research activities: US Interagency collaboration, 2001
JW LeDuc et al.
EMERGING INFECTIOUS DISEASES (2002)
Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo
C Manichanh et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Adenovirus infections in adult recipients of blood and marrow transplants
AM La Rosa et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
